Janssen's Tremfya continues to post gains, but may soon face competition as Sun Dermatology readies for the launch of Ilumya (tildrakizumab), the second IL-23 inhibitor to be introduced in the U.S. market, according to a new report from Spherix Global Insights
Read MoreThose with periodontal disease are over 50% more likely to have psoriasis than those that don't have the oral infection. Another trigger for psoriasis may be periodontal disease. And this is another reason to maintain good oral health.
Read MoreOrganic Salon Systems introduces a highly advanced, natural hair care range designed specifically to calm, cleanse, and rebalance scalps that are prone to irritation due to eczema, psoriasis, dermatitis, or even chemical salon services.
Read MoreWhile over 20% of salon clients in the United States have eczema, psoriasis, scalp dermatitis, or chronic scalp irritation; very few salons currently have any capacity of servicing them leaving a valuable and loyal market untapped.
Read MoreDetroit, MI - September 1, 2009 - Detroit-based hair & scalp care manufacturers Derjers International continues its unprecedented rise in the hair care industry by garnering the attention of mainstream media.
Read More